---
document_datetime: 2023-09-21 21:26:40
document_pages: 17
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ovitrelle-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ovitrelle-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 30.7529589
conversion_datetime: 2025-12-15 19:39:52.023597
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Ovitrelle

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued² / amended on   | Product Information affected3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| N/0087               | Minor change in labelling or package leaflet not connected with the SPC(Art.61.3 Notification)                                                  | 16/11/2022                          |                                            | PL                              |           |
| IA/0086              | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits | 04/07/2022                          | n/a                                        |                                 |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedfor all otherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics,annex II, labelling,package leaflet).The CD is issued within twomonths of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation(EU) No.712/2012, or within one yearfor other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0085   | B.I.b.2.a-Change in test procedure for AS or startingmaterial/reagent/intermediate-Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                        | 10/02/2022   | n/a        |                        |                                                                                                                                                                     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0084   | B.IV.1.z-Change of a measuring or administration device-Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 18/10/2021   | 14/10/2022 | SmPC, Labelling and PL | Updateof theproductinformationrelatedtothe introductionof asecondinjectionneedleineachboxof Ovitrelle250mcg solutionforinjection inpre-filledpen (EU/1/00/165/008). |
| IA/0083/G | This was an application for a group of variations. B.I.b.1.c-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Additionof anew specification parameter to the specification with its corresponding testmethod B.I.b.1.b-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Tightening of specification limits B.I.b.1.b-Change in the specificationparameters and/or limits of an AS,starting material/intermediate/reagent-Tightening of specification limits | 03/08/2021   | n/a        |                        |                                                                                                                                                                     |
| 11/0081   | Changes in sections 4.1, 4.2, 4.4 and 4.6 of the SmPCinordertoupdatetheterminology,in4.3to amendexistingcontraindicationsandin4.8todelete certain adverse drug reactions(ADRs)and add gastrointestinal ADRs with frequency common, with theaimtoaligntheProductInformationwithsimilar                                                                                                                                                                                                                                                                                 | 15/10/2020   | 11/10/2021 | SmPC, Labelling and PL |                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|                   | textprovidedfor othergonadotropinproducts. ThePackage Leaflet is updated accordingly.In addition,theMAH took theopportunitytobring the PI inline with thelatestQRD templateversion10.1 and performed minor linguistic changes. C.I.4 -Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |            |                  |                                |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|--------------------------------|
| IA/0082           | A.7-Administrativechange-Deletionof manufacturingsites                                                                                                                                                                                                                                                                                            | 02/09/2020 | n/a        |                  |                                |
| PSUSA/736/2 01909 | PeriodicSafetyUpdateEUSingle assessment- choriogonadotropin alfa                                                                                                                                                                                                                                                                                  | 17/04/2020 | n/a        |                  | PRACRecommendation-maintenance |
| IB/0079           | B.III.1.b.2-Submission of a new/updated or deletion of Ph.Eur.TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma newor analreadyapprovedmanufacturer                                                                                                                                  | 20/01/2020 | n/a        |                  |                                |
| 11/0078           | B.I.a.2.c-Changes in the manufacturing process of theAS-Thechangereferstoa-]substanceinthe manufactureofabiological/immunologicalsubstance whichmayhavea significant impacton themedicinal productandisnotrelated to aprotocol                                                                                                                    | 06/06/2019 | n/a        |                  |                                |
| N/0077            | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                            | 29/11/2018 | 23/08/2019 | Labelling and PL |                                |

<div style=\"page-break-after: always\"></div>

| IA/0076   | B.II.b.5.a -Change to in-process tests orlimits applied during the manufacture of the finished product-Tighteningofin-processlimits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 26/11/2018   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                       |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| T/0075    | TransferofMarketingAuthorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 03/09/2018   | 20/09/2018 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                       |
| I1/0073/G | This was an application for a group of variations. Updateofsection4.8oftheSmPCinorder to indicatethatthromboembolismcan alsooccur withoutthepresenceofovarianhyperstimulation syndrome (OHSS). The package leaflet and risk managementplan(RMP)version6.0areupdated accordingly.TheRMPis alsoupdated toextend the importantpotentialriskof`misuse'to'weightloss and anabolic growth promoting effect'.In addition, themarketing authorisationholder(MAH)took the opportunity to update the list of local representatives inthepackageleaflet,tomakeeditorialchangesin theproduct information and in theAnnexA(list of authorisedpresentations).TheMAHalsotookthe opportunity tomakesomerevisionsintheRMP. C.I.4 -Change(s) in the SPC, Labelling or PL due to new quality,preclinical, clinical orpharmacovigilance data C.1.11.b -Introduction of, or change(s) to, the obligations andconditionsof amarketing authorisation,including theRMP-Implementation of | 06/09/2018   | 23/08/2019 | SmPC andPL             | Thromboembolism both in association with and separate from ovarianhyperstimulation syndrome(OHSS)hasbeen reported in post-marketing.Thefrequency of the occurrenceofthromboembolismremainsveryrare. Misuseincludingweight loss and anabolic growthpromoting effect is an important potential risk listed in the risk management plan. |

<div style=\"page-break-after: always\"></div>

|           | by new additional data to be submitted by the MAH where significantassessment isrequired                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     |                                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------------|
| IA/0074/G | Thiswas an applicationfor a groupof variations. B.1I.e.1.b.3-Change in immediate packaging of the finished product - Change in type/addition of a new container - Deletion of an immediate packaging container without a complete deletion of a strength orpharmaceuticalform B.II.e.2.a-Change in the specification parameters and/orlimitsoftheimmediatepackagingofthe finished product -Tightening of specification limits B.II.e.3.a-Change in test procedure for the immediatepackaging of thefinishedproduct-Minor | 17/08/2018 | n/a | changes to an approved test procedure |
|           | Thiswas an applicationfor agroupof variations. B.Ill.1.b.2-Submissionofanew/updatedor deletion ofPh.Eur.TSE Certificate ofSuitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma neworanalreadyapprovedmanufacturer B.Ill.1.b.4-Submissionofanew/updatedor deletionofPh.Eur.TSECertificateofSuitability- Deletion of certificates(in casemultiplecertificates exist per material)                                                                                                   | 30/08/2017 | n/a | IB/0072/G                             |
| IB/0071   | B.I.a.2.a - Changes in the manufacturing process of theAS-Minorchangeinthemanufacturingprocess                                                                                                                                                                                                                                                                                                                                                                                                                           | 02/06/2017 | n/a |                                       |

<div style=\"page-break-after: always\"></div>

|                   | of the AS                                                                                                                                                                                                                                                                                  |            |            |                            |                                |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------|--------------------------------|
| PSUSA/736/2 01609 | PeriodicSafetyUpdateEUSingle assessment- choriogonadotropin alfa                                                                                                                                                                                                                           | 05/05/2017 | n/a        |                            | PRACRecommendation-maintenance |
| IB/0070           | B.I.b.2.e -Change in test procedure for AS or startingmaterial/reagent/intermediate-Other changesto a testprocedure(includingreplacement or addition) for the AS or a starting material/intermediate                                                                                       | 22/03/2017 | n/a        |                            |                                |
| IA/0069/G         | This was an application for a group of variations. B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product-Minor changes toan approved test procedure | 17/02/2017 | n/a        |                            |                                |
| IB/0066           | C.I.z-Changes(Safety/Efficacy)ofHuman and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                       | 04/12/2016 | 10/11/2017 | Annex II, Labelling and PL |                                |
| IB/0067           | B.I.a.4.z-Change to in-process tests orlimits applied during the manufacture of the AS - Other variation                                                                                                                                                                                   | 22/11/2016 | n/a        |                            |                                |
| IA/0065           | B.II.e.6.b-Change in any part of the (primary) packagingmaterialnotincontactwiththefinished product formulation - Change that does not affect theproductinformation                                                                                                                        | 22/07/2015 | n/a        |                            |                                |

<div style=\"page-break-after: always\"></div>

| IG/0500   | C.I.8.a-Introductionofor changesto a summary of Pharmacovigilancesystem-ChangesinQPPV (includingcontact details)and/or changesin the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 17/11/2014   | n/a   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0063   | C.1.11.z-Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation，includingtheRMp-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 25/09/2014   | n/a   |
| IA/0061/G | This was an applicationfor a group of variations. B.III.2.z-Change to comply with Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation B.III.2.z - Change to comply with Ph. Eur. or with a nationalpharmacopoeiaofaMemberState-Other variation B.III.2.z-Change to comply with Ph.Eur. or with a nationalpharmacopoeiaofaMemberState-Other variation B.IIl.2.z-Change to comply with Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation B.IIl.2.z-Change tocomplywithPh.Eur.orwith a nationalpharmacopoeiaofaMemberState-Other variation B.III.2.z-Change to comply with Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation B.II1.2.z-Change to complywith Ph.Eur.orwith a | 29/07/2014   | n/a   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | nationalpharmacopoeiaofaMemberState-Other variation B.III.2.z-Change to comply with Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation B.II1.2.z-Change to complywith Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation B.III.2.z -Change to comply with Ph.Eur. or with a nationalpharmacopoeiaofaMemberState-Other variation B.I.b.1.d-Change in the specification parameters and/orlimitsof anAS,starting material/intermediate/reagent-Deletionofanon- significantspecificationparameter(e.g.deletion of anobsoleteparameter) B.I.b.1.d-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Deletionofanon- significantspecificationparameter(e.g.deletion of anobsoleteparameter) B.I.b.1.c-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specificationparametertothe specificationwithits   |            |     |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IG/0461 | C.I.8.a-Introductionof or changesto a summary of Pharmacovigilancesystem-ChangesinQPPV (including contact details) and/or changes in the PSMFlocation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 22/07/2014 | n/a |

<div style=\"page-break-after: always\"></div>

| PSUV/0059   | PeriodicSafetyUpdate                                                                                                                                                                                                                                                                                                                                        | 08/05/2014   | n/a        |                                   | PRACRecommendation-maintenance   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------------------|----------------------------------|
| IB/0060     | Updateof theProductInformationtocomplywith QRDtemplateversion9. C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                       | 24/04/2014   | 13/05/2015 | SmPC, Annex II, Labelling  and PL |                                  |
| N/0055      | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                      | 07/11/2013   | 17/12/2013 | PL                                |                                  |
| IB/0057     | B.I.a.2.a-Changes in the manufacturing process of theAS-Minor changein themanufacturingprocess of theAS                                                                                                                                                                                                                                                     | 29/10/2013   | n/a        |                                   |                                  |
| IA/0058/G   | Thiswas an applicationfor a groupof variations. B.I.b.1.d-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Deletionofanon- significantspecificationparameter(e.g.deletion of anobsoleteparameter) B.III.2.z-Change to comply with Ph.Eur.or with a nationalpharmacopoeiaofaMemberState-Other variation | 21/10/2013   | n/a        |                                   |                                  |
| IB/0056     | B.II.b.1.b-Replacement or addition of a manufacturing site for the FP - Primary packaging site                                                                                                                                                                                                                                                              | 16/10/2013   | n/a        |                                   |                                  |

<div style=\"page-break-after: always\"></div>

| IB/0052   | B.I.b.2.e - Change in test procedure for AS or startingmaterial/reagent/intermediate-Other changes to a testprocedure(includingreplacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                  | 30/08/2013   | n/a   |                                             |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|---------------------------------------------|
| IA/0054/G | This was an application for a group of variations. A.4-Administrative change-Change in the name and/oraddressof amanufacturerorsupplierofthe AS，startingmaterial,reagentorintermediateused in themanufactureof theAS A.4-Administrative change -Change in the name and/oraddressof amanufacturerorsupplierof the AS,startingmaterial,reagentorintermediateused in themanufactureoftheAS | 19/08/2013   | n/a   |                                             |
| IA/0053   | B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor changestoanapprovedtestprocedure                                                                                                                                                                                                                                                                | 28/06/2013   | n/a   |                                             |
|           | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. Change to thecontrol of the activesubstance B.I.a.4.b -Change to in-process tests or limits appliedduring themanufactureof theAS-Addition                                                                                                           | 30/05/2013   | n/a   | WS/0380 of a new in-process test and limits |

<div style=\"page-break-after: always\"></div>

|         | C.I.7.a-Deletion of-a pharmaceutical form                                                                                                                                                                                                                                                                                                                                                              | 14/12/2012   | 17/12/2013   | SmPC, Annex II, Labelling and PL   | IB/0050   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|-----------|
| IA/0049 | B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor changes to an approved test procedure                                                                                                                                                                                                                                                                          | 12/11/2012   | n/a          |                                    |           |
|         | C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                  | 11/10/2012   | n/a          |                                    | IG/0224   |
| IB/0041 | C.I.3.a-Implementation of change(s)requested following the assessment of an USR, class labelling, a PSUR,RMP,FUM/SO,datasubmittedunderA45/46， oramendmentstoreflectaCoreSPC-Changeswith NOnewadditionaldata aresubmittedbytheMAH                                                                                                                                                                       | 21/10/2011   | n/a          | SmPC and PL                        |           |
|         | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. NewTSEcertificateforarawmaterialusedinthe manufactureofthe activesubstance. B.Ill.1.b.2-Submissionofa neworupdatedPh.Eur. TSECertificateofsuitability-Newcertificatefora startingmaterial/reagent/intermediate/orexcipient fromaneworanalreadyapprovedmanufacturer | 21/07/2011   | 21/07/2011   |                                    | WS/0148   |
| IG/0087 | B.III.2.b-Change to comply withPh.Eur.or with a nationalpharmacopoeiaofaMemberState-Change tocomplywithanupdateoftherelevantmonograph                                                                                                                                                                                                                                                                  | 18/07/2011   | n/a          |                                    |           |

<div style=\"page-break-after: always\"></div>

|           | ofthePh.Eur.ornationalpharmacopoeiaofa MemberState                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |                        |                                                                                                                                                                                                                                                                               |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0076/G | This was an application for a group of variations. C.I.9.a-Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.b-Changes to anexisting pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h-Changes toan existingpharmacovigilance system as described in the DDPS - Other change(s) totheDDPSthatdoesnotimpactontheoperationof the pharmacovigilance system | 01/07/2011 | n/a        |                        |                                                                                                                                                                                                                                                                               |
| X/0040    | Toregister an additional pharmaceutical form: solution for injection in pre-filled pen (250 micrograms/0.5 ml) Annex I_2.(d)Change or addition of a new pharmaceuticalform                                                                                                                                                                                                                                                                                    | 14/04/2011 | 23/06/2011 | SmPC, Labelling and PL | TheMAHregisteredanewpharmaceuticalform:solution for injection in a cartridge pre-installed in a disposable pen. Nochangeshavebeenmadetothecurrentlyapproved strength(250micrograms),drug substance,drugproduct formulation, indication, posology and route of administration. |
| IG/0069   | A.7-Administrativechange-Deletionof manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                       | 12/05/2011 | n/a        |                        |                                                                                                                                                                                                                                                                               |
| N/0039    | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                                                                                           | 22/01/2010 | n/a        | PL                     |                                                                                                                                                                                                                                                                               |
| IB/0038   | IB_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening                                                                                                                                                                                                                                                                                                                                                                   | 23/10/2009 | n/a        |                        |                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|         | IA_01_Change in the name and/or addressof the marketing authorisationholder                                                                                                   | 09/07/2009   | n/a        | SmPC, Labelling and PL   | IA/0037   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|--------------------------|-----------|
|         | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph.Eur.cert.avail.) IA_05_Change in the name and/or address of a manufacturerofthefinishedproduct | 31/03/2009   | n/a        | Annex II and PL          | IA/0036   |
| IA/0035 | IA_o5_Change in the name and/or address of a manufacturerofthefinishedproduct                                                                                                 | 07/11/2008   | n/a        | Annex II and PL          |           |
|         | IB_31_a_Change to in-process tests/limits during manufacture-tighteningofin-processlimits                                                                                     | 06/11/2008   | n/a        |                          | IB/0034   |
| I1/0032 | Change(s) to the manufacturing process for the activesubstance                                                                                                                | 30/05/2008   | 05/06/2008 |                          |           |
| I1/0031 | Quality changes                                                                                                                                                               | 24/04/2008   | 06/05/2008 |                          |           |
|         | IA_o5_Change in the name and/or addressof a manufacturerofthefinishedproduct                                                                                                  | 12/02/2008   | n/a        |                          | IA/0033   |
| II/0028 | Change(s)to the testmethod(s)and/or specifications for the active substance                                                                                                   | 24/01/2008   | 28/01/2008 |                          |           |
| IB/0029 | IB_36_a_Changeinshapeordimensionsof the container/closure-sterileph.forms/biologicals                                                                                         | 09/10/2007   | n/a        |                          |           |
|         | IA_28_Change inanypartofprimarypackaging materialnotincontactwithfinishedproduct                                                                                              | 01/10/2007   | n/a        |                          | IA/0030   |

<div style=\"page-break-after: always\"></div>

| I1/0027   | Change(s)to themanufacturingprocessforthe finished product                                       | 19/07/2007   | 08/08/2007   |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|--------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0024   | Change(s) to the manufacturing process for the finished product                                  | 19/07/2007   | 08/08/2007   |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| N/0026    | Minorchange inlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)             | 18/06/2007   | n/a          | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0025   | IB_37_a_Change in the specification of the finished product - tightening of specification limits | 15/03/2007   | n/a          |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| I1/0023   | Change(s)to themanufacturingprocessforthe active substance                                       | 16/11/2006   | 20/11/2006   |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| N/0022    | Minor change in labelling or package leaflet not connectedwiththeSPC(Art.61.3Notification)       | 09/08/2006   | n/a          | Labelling                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| R/0020    | Renewalofthemarketingauthorisation.                                                              | 15/09/2005   | 31/01/2006   | SmPC, Annex II, Labelling and PL | BasedontheCHMPreviewoftheavailableinformation,the CHMPconsidered thatthe quality,theefficacy and the safetyof thismedicinalproductcontinuestobeadequately andsufficientlydemonstratedandthereforeconsideredby consensusthatthebenefit/riskprofileofOvitrelleinthe approved therapeutic indication remains favourable. The CommitteeforMedicinalProductsforHumanUse recommended thereforetherenewaloftheMarketing Authorisationfor Ovitrelle.The CHMPwas of the opinion that no additional 5-year renewal is required. |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                  |            |            |                                 | CommunityMarketingAuthorisation.Thefollowing annexes have been amended:I, II,IIIA and IIIB.Future PSURs submission will takeplacein accordance toArticle24(3)of RegulationEC726/2004.                                                                                                                                            |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0021 | Update of Summary of Product Characteristics, Labelling andPackageLeaflet. UpdateofSummaryofProductCharacteristics, Labelling andPackage Leaflet | 15/09/2005 | 25/10/2005 | SmPC,Annex II, Labelling and PL | TheMAHapplied toupdatetheSPCfurther to the AssessmentReportofPSuR6ofOvitrelletoreflectthe CoreSafetyInformationwithregardstocomplicationsof OvarianHyperstimulation syndrome andtoinclude allergic reactions presenting as a rash in the 4.8 section as very rare possible side effects.As a consequence,thePL was also updated. |
| 11/0019 | Change(s) to the test method(s) and/or specificationsforthe activesubstance                                                                      | 15/09/2005 | 05/10/2005 |                                 |                                                                                                                                                                                                                                                                                                                                  |
| IA/0018 | IA_16_b_Submission of new TSE certificate relating toactivesubstance-othersubstances                                                             | 24/01/2005 | n/a        |                                 |                                                                                                                                                                                                                                                                                                                                  |
| N/0016  | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification)                                                           | 11/11/2004 | n/a        | PL                              |                                                                                                                                                                                                                                                                                                                                  |
| IA/0017 | IA_05_Changeinthenameand/oraddressofa manufacturerofthefinishedproduct                                                                           | 06/10/2004 | n/a        |                                 |                                                                                                                                                                                                                                                                                                                                  |
| N/0015  | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                              | 27/07/2004 | n/a        | PL                              |                                                                                                                                                                                                                                                                                                                                  |
| IB/0014 | IB_42_a_01_Change in shelf-life of finished product -aspackagedforsale                                                                           | 10/03/2004 | n/a        | SmPC                            |                                                                                                                                                                                                                                                                                                                                  |
| IA/0013 | IA_O6_a_Change inATCcode:Medicinal productsfor                                                                                                   | 27/11/2003 | n/a        | SmPC                            |                                                                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

|        | human use                                                                                  |            |            |                                  |         |
|--------|--------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------|
| X/0007 | X-3-iv_Change or additionof a newpharmaceutical form                                       | 24/07/2003 | 24/10/2003 | SmPC, Annex II, Labelling and PL |         |
|        | 31_Change incontainershape                                                                 | 08/10/2003 | 23/10/2003 |                                  | 1/0011  |
|        | 01_Changeinor additionof manufacturingsite(s)for part or all of the manufacturing process  | 08/10/2003 | 23/10/2003 |                                  | 1/0010  |
|        | Change(s)to the testmethod(s)and/or specificationsfortheactivesubstance                    | 25/09/2003 | 02/10/2003 |                                  | I1/0012 |
|        | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3Notification)      | 10/02/2003 | 17/03/2003 | PL                               | N/0009  |
|        | 15a_ChangeinIPCsappliedduringthemanufacture of the product                                 | 16/01/2003 | 22/01/2003 |                                  | 1/0008  |
|        | 01_Changeinor additionofmanufacturingsite(s)for partor allofthemanufacturingprocess        | 13/09/2002 | 27/09/2002 |                                  | 1/0004  |
| 1/0005 | 01_Changeinthenameofamanufacturerofthe medicinalproduct                                    | 21/08/2002 | 10/09/2002 |                                  |         |
|        | 11b_Change in supplier of an intermediate compoundused inmanufactureof theactive substance | 21/08/2002 | n/a        |                                  | 1/0006  |
| 1/0003 | 12a_Changeinspecificationof starting material/intermediateusedinmanuf.oftheactive          | 22/03/2002 | 10/04/2002 |                                  |         |

<div style=\"page-break-after: always\"></div>

| substance                                                                      |            |            |                        |        |
|--------------------------------------------------------------------------------|------------|------------|------------------------|--------|
| 03_Changeinthename and/or addressof the marketing authorisationholder          | 20/07/2001 | 10/09/2001 | SmPC, Labelling and PL | 1/0002 |
| 02_Change in the name of themedicinal product (eitherinventednameofcommonname) | 20/07/2001 | 10/09/2001 | SmPC, Labelling and PL | 1/0001 |